🔎 Trials Near Me

Home › Basal Cell Carcinoma › Florida

Pag-aaral pangklinika para sa Basal Cell Carcinoma sa Florida

7 pag-aaral para sa Basal Cell Carcinoma ang naghahanap ng mga kalahok sa mga site sa Florida.

Opisyal na teksto ng pag-aaral (English)

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

  • UM Sylvester Comprehensive Cancer Center at Aventura, Aventura
  • UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
  • at 4 pa
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT05896839

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

  • AdventHealth Celebration, Celebration
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05592626

L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)

  • H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., Tampa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT07227350

L19IL2/TNF in Patients With Basal Cell Carcinoma

  • H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., Tampa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 21, 2026 · NCT07227870

A Beta-only IL-2 ImmunoTherapY Study

  • Boca Raton Regional Hospital, Boca Raton
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 9, 2025 · NCT05086692

To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma

  • Research Site, Boca Raton
  • Research Site, Coral Springs
  • Research Site, Cutler Bay
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 20, 2024 · NCT06344052

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.